menu ☰
menu ˟

FDA gives orphan drug designation for retinitis pigmentosa gene therapy

03 Aug 2017
The FDA has given orphan drug designation to a gene therapy product intended for treatment of X-linked retinitis pigmentosa, Applied Genetic Technologies Corp. announced in a press release.The drug candidate, which is intended specifically to treat X...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.